Remoxipride for psychosis with tardive dyskinesia

M. Matar; P. Lokshin; Z. Kaplan; R. H. Belmaker

Remoxipride for psychosis with tardive dyskinesia

M. Matar, P. Lokshin, Z. Kaplan, R. H. Belmaker

Research output: Contribution to journal › Article › peer-review

Abstract

Remoxipride is a new-generation antipsychotic drug registered and in current use in a number of countries in Europe. It was designed to have fewer extrapyramidal side-effects. A 37-year-old woman with psychosis and tardive dyskinesia, successfully treated with remoxipride, is presented.

Original language	English
Pages (from-to)	30+62
Journal	Harefuah
Volume	128
Issue number	1
State	Published - 1 Jan 1995
Externally published	Yes

ASJC Scopus subject areas

General Medicine

Cite this

@article{73e9784d3ddb4dde881a50fe2717a530,

title = "Remoxipride for psychosis with tardive dyskinesia",

abstract = "Remoxipride is a new-generation antipsychotic drug registered and in current use in a number of countries in Europe. It was designed to have fewer extrapyramidal side-effects. A 37-year-old woman with psychosis and tardive dyskinesia, successfully treated with remoxipride, is presented.",

author = "M. Matar and P. Lokshin and Z. Kaplan and Belmaker, {R. H.}",

year = "1995",

month = jan,

day = "1",

language = "English",

volume = "128",

pages = "30+62",

journal = "Harefuah",

issn = "0017-7768",

publisher = "Israel Medical Association",

number = "1",

}

TY - JOUR

T1 - Remoxipride for psychosis with tardive dyskinesia

AU - Matar, M.

AU - Lokshin, P.

AU - Kaplan, Z.

AU - Belmaker, R. H.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - Remoxipride is a new-generation antipsychotic drug registered and in current use in a number of countries in Europe. It was designed to have fewer extrapyramidal side-effects. A 37-year-old woman with psychosis and tardive dyskinesia, successfully treated with remoxipride, is presented.

AB - Remoxipride is a new-generation antipsychotic drug registered and in current use in a number of countries in Europe. It was designed to have fewer extrapyramidal side-effects. A 37-year-old woman with psychosis and tardive dyskinesia, successfully treated with remoxipride, is presented.

UR - http://www.scopus.com/inward/record.url?scp=0028915992&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0028915992

SN - 0017-7768

VL - 128

SP - 30+62

JO - Harefuah

JF - Harefuah

IS - 1

ER -

Remoxipride for psychosis with tardive dyskinesia

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this